GLIDAPAFLOZIN TRIO 1 FORTE 

Dapagliflozin , glimepiride & metformin Hydrochloride ( extended Release ) 

GLIDAPAFLOZIN TRIO 1 FORTE: A Comprehensive Overview

Introduction to GLIDAPAFLOZIN TRIO 1 FORTE

GLIDAPAFLOZIN TRIO 1 FORTE refers to a combination medication containing dapagliflozin, glimepiride, and metformin hydrochloride (extended-release). This potent trio is primarily used in the management of type 2 diabetes to improve blood sugar control.

Components of GLIDAPAFLOZIN TRIO 1 FORTE

Dapagliflozin

• Mechanism of Action: Inhibits sodium-glucose co-transporter 2 (SGLT2) in the kidneys, promoting glucose excretion in urine.
• Benefits: Lowers blood glucose levels without increasing insulin secretion.

Glimepiride

• Mechanism of Action: Stimulates insulin release from pancreatic β-cells, enhancing glucose uptake by tissues.
• Benefits: Provides effective reduction in fasting and postprandial blood sugar levels.

Metformin Hydrochloride (Extended Release)

• Mechanism of Action: Decreases hepatic glucose production and intestinal absorption of glucose, improving insulin sensitivity.
• Benefits: Offers sustained blood sugar control due to extended-release formulation.

Therapeutic Advantages of GLIDAPAFLOZIN TRIO 1 FORTE

• Comprehensive Glycemic Control: By combining three distinct mechanisms of action, this medication offers robust blood sugar management.
• Convenience: Single-pill regimen improves patient adherence compared to taking multiple separate medications.
• Extended Glycemic Management: The extended-release form of metformin ensures longer-lasting blood sugar control, reducing the need for frequent dosing.

Clinical Considerations

• Patient Selection: Ideal for individuals with type 2 diabetes who require multi-faceted treatment approaches.
• Side Effects: Potential for urinary tract infections (due to dapagliflozin), hypoglycemia (due to glimepiride), and gastrointestinal disturbances (due to metformin).
• Monitoring and Adjustments: Regular monitoring of blood sugar levels, renal function, and potential side effects is essential to optimize treatment outcomes.

Conclusion

GLIDAPAFLOZIN TRIO 1 FORTE represents a significant advancement in the management of type 2 diabetes, offering a multi-targeted approach with the convenience of an extended-release formulation. Its comprehensive action on different aspects of glucose metabolism makes it a valuable option for patients needing potent glycemic control.  A group of highly skilled pharmaceutical professionals founded a specialist pharmaceutical in February 2018 such as Steris Healthcare Pvt Ltd.Sterispharma is a WHO, GMP, and ISO-certified pharma company based in Navi Mumbai. They provide quality medicines at the best price to customers in India as per the standard parameters of WHO. With a steris online pharmacy, you can buy and get home delivery of medicines at your doorsteps. Our main goal at Steris is to provide a wide range of healthcare goods to meet the various needs of the healthcare sector. Steris is dedicated to satisfying the needs of the healthcare industry, whether it be with regard to specialty treatments, rare disease meds, or necessary pharmaceuticals. Steris healthcare products range covers almost every cadre of requirement in today's Medical scenario, widely prescribed under categories like Cardiology, Asthama, Respiratory, Nasal, Diabetic, Endocrinology, Cadiology, Gastrology, Orthopaedic, Anti-infective/antibiotic, General, Urology, Neurology, Nephrology, Oncology, Gynaecology, Pediatric, Dental & Derma range of Products.

For further more information:

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com    

CALL:: 7877551268, 8209542042, 8955945010, 6377716668   

WHATSAPP:: MONA, HARSHITA, SAKSHI, SHWETA   

BUY NOW